Harvard Bioscience (HBIO) Stock: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$8.13
0.21 (2.65%)
▲
5d:
+1.37%
30d:
+1.12%
90d:
+32.2%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HBIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HBIO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.95
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $8.13, which is considered extended relative to its 30-day fair value range of $7.82 to $8.11. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.6) compared to its historical average (9.9). At these levels, the market is pricing in 8.4% annual earnings growth.
Technical Outlook: Technically, HBIO is in a strong uptrend. The price is approaching resistance at $8.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HBIO is in a strong uptrend. The price is approaching resistance at $8.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.82 -
$8.11
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($7.50)
- BULLISH: Expecting earnings turnaround to 8.4% growth with 11.1% revenue growth
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.82 -
$8.11
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.85
Resistance Level
$8.19
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.60
Wall Street Target
$7.50
(-7.7%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
-80.3%
Profit Margin
-11.9%
Valuation Premium vs History
+8.4% premium
PE vs Historical
12.6 vs 9.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.4%
(market-implied from PE analysis)
1-Year Target
$8.81
(+8%)
2-Year Target
$9.55
(+18%)
3-Year Target
$10.36
(+27%)
3-Yr Target (if PE normalizes)
(PE: 13→10)
PE COMPRESSION
$8.13
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 02, 2026 3:49 AM ET
Data refreshes hourly during market hours. Next update: 4:49 AM
Data refreshes hourly during market hours. Next update: 4:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
